nach oben

Erschienen in:

01.06.2019 | PTSD (S Creech and L Sippel, Section Editors)

Adjusting the Timeframe of Evidence-Based Therapies for PTSD-Massed Treatments

verfasst von: Jennifer Schuster Wachen, PhD, Katherine A. Dondanville, PsyD, Wyatt R. Evans, PhD, Kris Morris, PhD, Allison Cole, BS

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Current clinical practice guidelines for the treatment of post-traumatic stress disorder (PTSD) strongly recommend individual manualized trauma-focused therapy. However, it can be challenging for patients to complete a full course of treatment. There has been recent interest in modifying the format of evidence-based psychotherapies for PTSD to be delivered within a shorter time frame to reduce the likelihood of dropout and optimize the potential for a positive treatment outcome. This article will review the existing literature on massed psychotherapies for PTSD, including only the treatments highly recommended by the current PTSD treatment guidelines that have been modified to an intensive format.

Recent Findings

The literature supporting massed treatment formats for PTSD is limited to date. Two randomized clinical trials (RCTs) provide the strongest evidence for efficacy for prolonged exposure and cognitive therapy for PTSD, and preliminary studies of cognitive processing therapy and eye movement desensitization and reprocessing are promising.

Summary

Current results suggest that massed formats of existing evidence-based psychotherapies for PTSD are promising efficient and effective methods to expedite recovery from PTSD symptoms. Additional RCTs are needed to demonstrate the efficacy of these treatments in a range of patient populations.

Kessler RC, Aguilar-Gaxiola S, Alonso J, Benjet C, Bromet EJ, Cardoso G, et al. Trauma and PTSD in the WHO world mental health surveys. Eur J Psychotraumatol. 2017;8:sup5. https://doi.org/10.1080/20008198.2017.1353383.CrossRef

Rothbaum BO, Foa EB, Riggs DS, Murdock T, Walsh W. A prospective examination of post-traumatic stress disorder in rape victims. J Trauma Stress. 1992;5(3):455–75. https://doi.org/10.1002/jts.2490050309.CrossRef

Goldstein RB, Smith SM, Chou SP, Saha TD, Jung J, Zhang H, et al. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016;51(8):1137–48.CrossRefPubMedPubMedCentral

American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5: fifth edition. Arlington: American Psychiatric Publishing; 2013.CrossRef

American Psychological Association. Clinical practice guideline for the treatment of PTSD. 2017. https://www.apa.org/ptsd-guideline/ptsd.pdf.

International Society for Traumatic Stress Studies. New ISTSS Prevention and Treatment Guidelines. 2018. http://www.istss.org/treating-trauma/new-istss-prevention-and-treatment-guidelines.aspx.

Veterans Health Administration & Department of Defense. VA/DoD clinical practice guideline for the management of post-traumatic stress. 2017. https://www.healthquality.va.gov/guidelines/MH/ptsd/.

Imel ZE, Laska K, Jakupcak M, Simpson TL. Meta-analysis of dropout in treatments for posttraumatic stress disorder. J Consult Clin Psychol. 2013;81(3):394–404. https://doi.org/10.1037/a0031474.CrossRefPubMedPubMedCentral

•• Foa EB, McLean CP, Zang Y, Rosenfield D, Yadin E, Yarvis JS, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. J Am Med Assoc. 2018;319(4):354–64. https://doi.org/10.1001/jama.2017.21242. This study is the first published RCT of massed prolonged exposure.

10.

Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314(5):489–500. https://doi.org/10.1001/jama.2015.8370.CrossRefPubMed

11.

Gutner CA, Suvak MK, Sloan DM, Resick PA. Does timing matter? Examining the impact of session timing on outcome. J Consult Clin Psychol. 2016;84(12):1108–15. https://doi.org/10.1037/ccp0000120.CrossRefPubMedPubMedCentral

12.

Foa EB, Hembree EA, Rothbaum BO. Prolonged exposure therapy for PTSD. New York: Oxford University; 2007.

13.

Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986;99(1):20–35.CrossRefPubMed

14.

Peterson AL, Foa EB, Blount TH, McLean CP, Shah DV, Young-McCaughan S, et al. Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: design and methodology of a randomized clinical trial. Contemp Clin Trials. 2018;72:126–36.CrossRefPubMed

15.

Hendriks L, de Kleine RA, Broekman TG, Hendriks GJ, van Minnen A. Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts. Eur J Psychotraumatol. 2018;9:1. https://doi.org/10.1080/20008198.2018.1425574.CrossRef

16.

Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. 1993;6(4):459–473. https://doi.org/10.1002/jts.2490060405.

17.

Ehlers A, Clark DM. A cognitive model of posttraumatic stress disorder. Behav Res Ther. 2000;38:319–45. https://doi.org/10.1016/S0005-7967(99)00123-0.CrossRefPubMed

18.

•• Ehlers A, Hackmann A, Grey N, Wild J, Liness S, Albert I, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014;171(3):294–304. https://doi.org/10.1176/appi.ajp.2013.13040552. This study is the first and only RCT of intensive cognitive therapy for PTSD.

19.

Ehlers A, Clark DM, Hackmann A, Grey N, Liness S, Wild J, et al. Intensive cognitive therapy for PTSD: a feasibility study. Behav Cogn Psychother. 2010;38(4):383–98. https://doi.org/10.1017/S1352465810000214.CrossRefPubMedPubMedCentral

20.

Bryant RA, Moulds ML, Guthrie RM, Dang ST, Nixon RDV. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003;71:706–12.CrossRefPubMed

21.

Schnurr PP, Friedman MJ, Engel CC, Foa EB, Shea MT, Chow BK, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. J Am Med Assoc. 2007;297:820–30.CrossRef

22.

Murray H, El-Leithy S, Billings J. Intensive cognitive therapy for post-traumatic stress disorder in routine clinical practice: a matched comparison audit. Br J Clin Psychol. 2017;56(4):474–8. https://doi.org/10.1111/bjc.12150.CrossRefPubMed

23.

Foa EB. Posttraumatic stress diagnostic scale manual. Minneapolis: National Computer Systems Inc; 1995.

24.

Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):541–50. https://doi.org/10.4088/JCP.12r08225.CrossRef

25.

ClinicalTrials.gov. Massed cognitive processing therapy for combat-related PTSD identifier: NCT03808727. 2019. https://clinicaltrials.gov/ct2/show/NCT03808727?term=NCT038 08727&rank=1.

26.

Bryan CJ, Leifker FR, Rozek DC, Bryan AO, Reynolds ML, Oakey DN, et al. Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: results of a pilot, open-label, prospective cohort trial. J Clin Psychiatry. 2018;74:2070–81. https://doi.org/10.1002/jclp.22651.CrossRef

27.

Shapiro F. Eye movement desensitization and reprocessing: basic principles, protocols, and procedures (2nd ed.). 2001.

28.

Shapiro F. Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories. J Trauma Stress. 1989;2(2):199–223. https://doi.org/10.1002/jts.2490020207.CrossRef

29.

World Health Organization. https://www.who.int/.

30.

Bongaerts H, Minnen AV, Jongh AD. Intensive EMDR to treat patients with complex posttraumatic stress disorder: a case series. J EMDR Pract Res. 2017;11(2):84–95. https://doi.org/10.1891/1933-3196.11.2.84.CrossRef

31.

Hurley EC. Effective treatment of veterans with PTSD: comparison between intensive daily and weekly EMDR approaches. Front Psychol. 2018;9. https://doi.org/10.3389/fpsyg.2018.01458.

32.

• Van Woudenberg C, Voorendonk EM, Bongaerts H, Zoet HA, Verhagen M, Lee CW, et al. Effectiveness of an intensive treatment programme combining prolonged exposure and eye movement desensitization and reprocessing for severe post-traumatic stress disorder. Eur J Psychotraumatol. 2018;9:1. https://doi.org/10.1080/20008198.2018.1487225. This study is a large open trial of EMDR + PE.CrossRef

33.

• Harvey MM, Rauch SAM, Zalta AK, Sornborger J, Pollack MH, Bothbaum BO, et al. Intensive treatment models to address posttraumatic stress among post-9/11 warriors: the warrior care network. Focus. 2017;15:378–83. https://doi.org/10.1176/appi.focus.20170022. This article describes four different intensive outpatient program models for service members and veterans.

34.

Yasinski C, Sherrill AM, Maples-Keller JL, Rauch SA. Intensive outpatient prolonged exposure for PTSD in post-9/11 veterans and service-members: program structure and preliminary outcomes of the Emory Healthcare Veterans Program. Trauma Psychol News. 2017;12(3):14–7.

35.

Zalta AK, Held P, Smith DL, Klassen BJ, Lofgreen AM, Normand PS, et al. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018;18(1):242. https://doi.org/10.1186/s12888-018-1816-6.CrossRefPubMedPubMedCentral

Titel: Adjusting the Timeframe of Evidence-Based Therapies for PTSD-Massed Treatments
verfasst von: Jennifer Schuster Wachen, PhD
Katherine A. Dondanville, PsyD
Wyatt R. Evans, PhD
Kris Morris, PhD
Allison Cole, BS
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Current Treatment Options in Psychiatry / Ausgabe 2/2019
Elektronische ISSN: 2196-3061
DOI: https://doi.org/10.1007/s40501-019-00169-9

Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin

PTSD (S Creech and L Sippel, Section Editors)

Brief Novel Therapies for PTSD: Written Exposure Therapy

PTSD (S Creech and L Sippel, Section Editors)

New-generation Antipsychotics and Cardiovascular Risk

Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)

Current State of the Problem: Opioid Overdose Rates and Deaths

Substance Use Disorders (FG Moeller, Section Editor)

Dealing with Complexity and Comorbidity: Opportunity for Transdiagnostic Treatment for PTSD

PTSD (S Creech and L Sippel, Section Editors)

Augmenting the Treatment of PTSD with Ketamine—a Review

PTSD (S Creech and L Sippel, Section Editors)

Neu im Fachgebiet Psychiatrie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Bipolare Störung
Interview

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

DGPPN 2024
Kongressbericht

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Einer von sieben Frauen macht die Menopause sehr zu schaffen

15.01.2025
Menopause
Nachrichten

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Depressive Senioren fahren besonders riskant

14.01.2025
Altersdepression
Nachrichten

Beim Autofahren machen ältere Depressive häufiger eine Vollbremsung, gehen öfter zu schnell in Kurven und halten sich seltener an Tempolimits als Senioren ohne Depression. Offenbar scheint eine Depression eine riskante Fahrweise im Alter zu verstärken.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Adjusting the Timeframe of Evidence-Based Therapies for PTSD-Massed Treatments